Brainstorm Cell Therapeutics Stock Probability of Future Stock Price Finishing Over 7.90
| BCLI Stock | USD 1.74 0.12 7.41% |
Brainstorm |
Brainstorm Cell Target Price Odds to finish over 7.90
The tendency of Brainstorm Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 7.90 or more in 90 days |
| 1.74 | 90 days | 7.90 | near 1 |
Based on a normal probability distribution, the odds of Brainstorm Cell to move over $ 7.90 or more in 90 days from now is near 1 (This Brainstorm Cell Therapeutics probability density function shows the probability of Brainstorm Stock to fall within a particular range of prices over 90 days) . Probability of Brainstorm Cell Ther price to stay between its current price of $ 1.74 and $ 7.90 at the end of the 90-day period is about 77.6 .
Given the investment horizon of 90 days Brainstorm Cell Therapeutics has a beta of -1.07 suggesting Additionally Brainstorm Cell Therapeutics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Brainstorm Cell Price Density |
| Price |
Predictive Modules for Brainstorm Cell
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Brainstorm Cell Ther. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Brainstorm Cell Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Brainstorm Cell is not an exception. The market had few large corrections towards the Brainstorm Cell's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Brainstorm Cell Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Brainstorm Cell within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -1.19 | |
β | Beta against Dow Jones | -1.07 | |
σ | Overall volatility | 1.16 | |
Ir | Information ratio | -0.24 |
Brainstorm Cell Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Brainstorm Cell for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Brainstorm Cell Ther can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Brainstorm Cell Ther generated a negative expected return over the last 90 days | |
| Brainstorm Cell Ther has high historical volatility and very poor performance | |
| Brainstorm Cell Ther may become a speculative penny stock | |
| Brainstorm Cell Ther has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (17.19 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Brainstorm Cell Therapeutics currently holds about 12.24 M in cash with (20.46 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.34. | |
| Brainstorm Cell Ther has a frail financial position based on the latest SEC disclosures | |
| Latest headline from MacroaxisInsider: Acquisition by Arbel Irit of 25333 shares of Brainstorm Cell at 0.75 subject to Rule 16b-3 |
Brainstorm Cell Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Brainstorm Stock often depends not only on the future outlook of the current and potential Brainstorm Cell's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Brainstorm Cell's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 43.1 M | |
| Cash And Short Term Investments | 1.3 M |
Brainstorm Cell Technical Analysis
Brainstorm Cell's future price can be derived by breaking down and analyzing its technical indicators over time. Brainstorm Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Brainstorm Cell Therapeutics. In general, you should focus on analyzing Brainstorm Stock price patterns and their correlations with different microeconomic environments and drivers.
Brainstorm Cell Predictive Forecast Models
Brainstorm Cell's time-series forecasting models is one of many Brainstorm Cell's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Brainstorm Cell's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Brainstorm Cell Ther
Checking the ongoing alerts about Brainstorm Cell for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Brainstorm Cell Ther help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Brainstorm Cell Ther generated a negative expected return over the last 90 days | |
| Brainstorm Cell Ther has high historical volatility and very poor performance | |
| Brainstorm Cell Ther may become a speculative penny stock | |
| Brainstorm Cell Ther has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (17.19 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Brainstorm Cell Therapeutics currently holds about 12.24 M in cash with (20.46 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.34. | |
| Brainstorm Cell Ther has a frail financial position based on the latest SEC disclosures | |
| Latest headline from MacroaxisInsider: Acquisition by Arbel Irit of 25333 shares of Brainstorm Cell at 0.75 subject to Rule 16b-3 |
Check out Brainstorm Cell Backtesting, Brainstorm Cell Valuation, Brainstorm Cell Correlation, Brainstorm Cell Hype Analysis, Brainstorm Cell Volatility, Brainstorm Cell History as well as Brainstorm Cell Performance. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Brainstorm Cell. If investors know Brainstorm will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Brainstorm Cell listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.45) | Return On Assets (1.78) | Return On Equity (11.22) |
The market value of Brainstorm Cell Ther is measured differently than its book value, which is the value of Brainstorm that is recorded on the company's balance sheet. Investors also form their own opinion of Brainstorm Cell's value that differs from its market value or its book value, called intrinsic value, which is Brainstorm Cell's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Brainstorm Cell's market value can be influenced by many factors that don't directly affect Brainstorm Cell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Brainstorm Cell's value and its price as these two are different measures arrived at by different means. Investors typically determine if Brainstorm Cell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Brainstorm Cell's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.